Correlation Between AN2 Therapeutics and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Fate Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Fate Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Fate Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AN2 and Fate is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Fate Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Fate Therapeutics
Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 0.75 times more return on investment than Fate Therapeutics. However, AN2 Therapeutics is 1.33 times less risky than Fate Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 106.00 in AN2 Therapeutics on September 26, 2024 and sell it today you would earn a total of 34.00 from holding AN2 Therapeutics or generate 32.08% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
AN2 Therapeutics vs. Fate Therapeutics
Performance |
Timeline |
AN2 Therapeutics |
Fate Therapeutics |
AN2 Therapeutics and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AN2 Therapeutics and Fate Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.AN2 Therapeutics vs. Fate Therapeutics | AN2 Therapeutics vs. Caribou Biosciences | AN2 Therapeutics vs. Karyopharm Therapeutics | AN2 Therapeutics vs. Hookipa Pharma |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |